LEJU [Leju] F-1/A: Amendment No. 2 FORM F-1 REGISTRATION STATEMENT Leju

[Amendment No. 2 FORM F-1 REGISTRATION STATEMENT Leju Holdings Limited Cayman Islands 7380 Not Applicable 15/F Floor, Shoudong International Plaza, No. 5 Building, Guangqu Home Law Debenture Corporate Services Inc. (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Z. Julie Gao, Esq. Skadden, Arps, Slate, Meagher & Flom LLP c/o 42/F,] [EXECUTION VERSION Strategic Cooperation Agreement Agreement This Strategic Cooperation Agreement (this “ th Effective Date day of March 2014 (the “ Party: Shanghai Yi Yue Information Technology Co., Ltd. 上海翊悦信息科技有限公司 (“Leju”) Address: 11/F, Qiushi Building, 383 Guangyan Road, Zhabei District, Shanghai 200072 Contact Person: Li-Lan Cheng Office Phone No.: +86 (21) 6133 0700 Email: chenglilan@ehousechina.com and Party: Shenzhen Tencent Computer] [EXECUTION VERSION SHARE PURCHASE AND SUBSCRIPTION AGREEMENT Agreement This Share Purchase and Subscription Agreement (this “ 1. Parent E-House (China) Holdings Limited, a company incorporated in the Cayman Islands (the “ 2. Company Leju Holdings Limited, a company incorporated in the Cayman Islands (the “ 3. Purchaser THL O Limited, a company incorporated in the British Virgin Islands (the “] [Execution Copy FIRST AMENDMENT TO THE SHARE PURCHASE AND SUBSCRIPTION AGREEMENT Amendment THIS FIRST AMENDMENT (this “ March 21 , 2014, by and among: (1) E-House (China) Holdings Limited Parent , a company incorporated in the Cayman Islands (the “ (2) Leju Holdings Limited Company , a company incorporated in the Cayman Islands (the “ (3) THL O Limited Purchaser] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We also consent to the reference to us under the headings “Experts” in such prospectus. Shanghai, China March 24, 2014 EX-23.1 5 a2219248zex-23_1.htm EX-23.1] [FANGDA PARTNERS 上海 Shanghai ·北京 Beijing ·深圳 Shenzhen ·香港 Hong Kong http://www.fangdalaw.com 中国上海市南京西路 1266 号 电子邮件 E-mail: email@fangdalaw.com 恒隆广场一期 32 楼 电 话 Tel.: 86-21-2208-1166 邮政编码： 200040 传 真 Fax: 86-21-5298-5577 文 号 Ref.: 13CF542 32/F Plaza 66 Tower 1 1266 Nanjing West Road Shanghai 200040, PRC To: Leju Holdings Limited March 24, 2014]

By | 2016-03-14T19:05:04+00:00 March 24th, 2014|Categories: Chinese Stocks, LEJU, Webplus ver|Tags: , , , , , |0 Comments
Read More

EJ [E-HOUSE (CHINA)] 6-K: E-House and Tencent Announce Tencent’s Strategic Investment in

[E-House and Tencent Announce Tencent’s Strategic Investment in Leju SHANGHAI/SHENZHEN, China, March 21, 2014 — E-House (China) Holdings Limited (“E-House”)(NYSE: EJ), a leading real estate services company in China, Leju Holdings Limited (“Leju”), a wholly-owned subsidiary of E-House and a leading provider of real estate online services, and Tencent Holdings Limited (“Tencent”, SEHK stock code: 00700), a leading provider of] [E-HOUSE (CHINA) HOLDINGS LIMITED Qiushi Building, 11/F No.383 Guangyan Road, Zhabei District Shanghai 200072 People’s Republic of China Form 20-F x Form 40-F o o o E-House (China) Holdings Limited]

By | 2016-03-22T04:39:35+00:00 March 24th, 2014|Categories: Chinese Stocks, EJ, Webplus ver|Tags: , , , , , |0 Comments
Read More

WUBA [58.com] F-1/A: (Original Filing)

[] [24 March, 2014 58.com Inc. Block E, The North American International Business Center Chaoyang District Beijing 100101 People’s Republic of China DIRECT LINE: E-MAIL OUR REF: YOUR REF: 852 2842 9531 Anna.Chong@conyersdill.com AC/al/#6383536 (M#879245) Dear Sirs, 58.com Inc. (the “Company”) Commission Registration Statement Securities Act Ordinary Shares Resolutions Certificate Date For the purposes of giving this opinion, we have examined] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the use in this Registration Statement on Form F-1 of 58.com Inc. of our report dated March 24, 2014, relating to the consolidated financial statements of 58.com Inc. which appears in such Registration Statement. We also consent to the references to us under the headings “Experts” in such Registration]

By | 2016-03-15T08:26:05+00:00 March 24th, 2014|Categories: Chinese Stocks, SEC Original, WUBA|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13D: (Original Filing)

[SCHEDULE 13D (Rule 13d-101) Skystar Bio-Pharmaceutical Company (Name of Issuer) Common Stock (Title of Class Of Securities) 830884102 (CUSIP Number) James M. Gregory SJ Strategic Investments, LLC 340 Martin Luther King, Jr. Boulevard, Suite 200 Bristol, TN 37620 (423) 989-8133 (Name, Address and Telephone Numbers of Person Authorized to Receive Notices and Communications) March 20, 2014 (Date of Event which]

By | 2016-03-27T16:16:43+00:00 March 24th, 2014|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine — -Preclinical development completed for H7N9 vaccine candidates that addresses significant BEIJING, January 29, 2014—Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration(CFDA) to commence human clinical trials for] [Sinovac’s EV71 Vaccine Phase III Clinical Trial Results Published in New — Study shows vaccine provides protection against EV71-associated hand, foot and mouth th The New England Journal of Medicine BEIJING, Feb. 26, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Phase III clinical trial results for its proprietary] [Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2013 BEIJING, March 12, 2014 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and whole year ended December 31, 2013, after market closes on Wednesday, March 19, 2014] [Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results - Conference call scheduled for Thursday, March 20, 2014 at 8:00 AM EDT - BEIJING, March 19, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and full year financial results for the period ended December] []

By | 2016-03-16T07:25:26+00:00 March 24th, 2014|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13D: SCHEDULE 13D (Rule 13d-101) Skystar Bio-Pharmaceutical Company (Name

[SCHEDULE 13D (Rule 13d-101) Skystar Bio-Pharmaceutical Company (Name of Issuer) Common Stock (Title of Class Of Securities) 830884102 (CUSIP Number) James M. Gregory SJ Strategic Investments, LLC 340 Martin Luther King, Jr. Boulevard, Suite 200 Bristol, TN 37620 (423) 989-8133 (Name, Address and Telephone Numbers of Person Authorized to Receive Notices and Communications) March 20, 2014 (Date of Event which]

By | 2016-03-27T16:17:53+00:00 March 24th, 2014|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] 6-K: Sinovac Files Clinical Trial Application with CFDA for

[Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine — -Preclinical development completed for H7N9 vaccine candidates that addresses significant BEIJING, January 29, 2014—Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration(CFDA) to commence human clinical trials for] [Sinovac’s EV71 Vaccine Phase III Clinical Trial Results Published in New — Study shows vaccine provides protection against EV71-associated hand, foot and mouth th The New England Journal of Medicine BEIJING, Feb. 26, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Phase III clinical trial results for its proprietary] [Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2013 BEIJING, March 12, 2014 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and whole year ended December 31, 2013, after market closes on Wednesday, March 19, 2014] [Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results - Conference call scheduled for Thursday, March 20, 2014 at 8:00 AM EDT - BEIJING, March 19, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and full year financial results for the period ended December] []

By | 2016-03-16T07:26:42+00:00 March 24th, 2014|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More

NOAH [Noah] 20-F: (Original Filing)

[Title of each class Name of exchange on which registered American depositary shares, two of which represent one ordinary share, par value US$0.0005 per share Ordinary shares, par value US$0.0005 per share* * None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the Issuer’s classes of capital or common stock as of] [LOAN AGREEMENT between Wang Jingbo Yin Zhe Zhang Xinjun Wei Yan He Boquan Yan Qianghua and Shanghai Noah Rongyao Investment Consulting Co., Ltd. December 26, 2013 Loan Agreement This Loan Agreement (hereinafter referred to as “this Agreement”) is made on December, 26, 2013 in Shanghai by and between: 1. Wang Jingbo, a PRC citizen; 2. Yin Zhe, a PRC citizen;] [List of Significant Consolidated Entities of Noah Holdings Limited* Name Jurisdiction of Relationship with us Shanghai Noah Rongyao Investment Consulting Co., Ltd. China Wholly-owned subsidiary (1) Shanghai Noah Financial Services Co., Ltd. China Wholly-owned subsidiary (2) Noah Insurance (Hong Kong) Limited Hong Kong Wholly-owned subsidiary Kunshan Noah Xingguan Investment Management Co., Ltd. China Wholly-owned subsidiary Noah Holdings (Hong Kong) Limited] [I, Jingbo Wang, certify that: 1. I have reviewed this annual report on Form 20-F of Noah Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification by the Principal Financial Officer I, Theresa Teng, certify that: 1. I have reviewed this annual report on Form 20-F of Noah Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jingbo Wang Chief Executive Officer EX-13.1 6 d679366dex131.htm EX-13.1] [Certification by the Principal Financial Officer 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Theresa Teng Chief Financial Officer EX-13.2 7 d679366dex132.htm EX-13.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-171541 on Form S-8 of our reports dated March 24, 2014, relating to the consolidated financial statements and financial statement schedule of Noah Holdings Limited, and the effectiveness of Noah Holdings Limited’s internal control over financial reporting, appearing in this Annual Report] [[Letterhead of Zhong Lun Law Firm] March 24, 2014 Noah Holdings Limited No. 32 Qinhuangdao Road, Building C Shanghai 200082 People’s Republic of China Dear Sirs, Yours faithfully, Zhong Lun Law Firm EX-15.2 9 d679366dex152.htm EX-15.2]

By | 2016-03-28T17:18:03+00:00 March 24th, 2014|Categories: Chinese Stocks, NOAH, SEC Original|Tags: , , , , , |0 Comments
Read More

NOAH [Noah] 20-F: Title of each class Name of exchange on

[Title of each class Name of exchange on which registered American depositary shares, two of which represent one ordinary share, par value US$0.0005 per share Ordinary shares, par value US$0.0005 per share* * None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the Issuer’s classes of capital or common stock as of] [LOAN AGREEMENT between Wang Jingbo Yin Zhe Zhang Xinjun Wei Yan He Boquan Yan Qianghua and Shanghai Noah Rongyao Investment Consulting Co., Ltd. December 26, 2013 Loan Agreement This Loan Agreement (hereinafter referred to as “this Agreement”) is made on December, 26, 2013 in Shanghai by and between: 1. Wang Jingbo, a PRC citizen; 2. Yin Zhe, a PRC citizen;] [List of Significant Consolidated Entities of Noah Holdings Limited* Name Jurisdiction of Relationship with us Shanghai Noah Rongyao Investment Consulting Co., Ltd. China Wholly-owned subsidiary (1) Shanghai Noah Financial Services Co., Ltd. China Wholly-owned subsidiary (2) Noah Insurance (Hong Kong) Limited Hong Kong Wholly-owned subsidiary Kunshan Noah Xingguan Investment Management Co., Ltd. China Wholly-owned subsidiary Noah Holdings (Hong Kong) Limited] [I, Jingbo Wang, certify that: 1. I have reviewed this annual report on Form 20-F of Noah Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification by the Principal Financial Officer I, Theresa Teng, certify that: 1. I have reviewed this annual report on Form 20-F of Noah Holdings Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jingbo Wang Chief Executive Officer EX-13.1 6 d679366dex131.htm EX-13.1] [Certification by the Principal Financial Officer 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Theresa Teng Chief Financial Officer EX-13.2 7 d679366dex132.htm EX-13.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-171541 on Form S-8 of our reports dated March 24, 2014, relating to the consolidated financial statements and financial statement schedule of Noah Holdings Limited, and the effectiveness of Noah Holdings Limited’s internal control over financial reporting, appearing in this Annual Report] [[Letterhead of Zhong Lun Law Firm] March 24, 2014 Noah Holdings Limited No. 32 Qinhuangdao Road, Building C Shanghai 200082 People’s Republic of China Dear Sirs, Yours faithfully, Zhong Lun Law Firm EX-15.2 9 d679366dex152.htm EX-15.2]

By | 2016-03-28T17:19:35+00:00 March 24th, 2014|Categories: Chinese Stocks, NOAH, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar